| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 347 | 197 | 13 |
| Full Text Views | 3 | 1 | 0 |
| PDF Downloads | 7 | 2 | 0 |
Korean Vivax Malaria
II. Curative Treatment with Pamaquine and Primaquine
Alf S. Alving
Alf S. Alving
Search for other papers by Alf S. Alving in
Current site
Google Scholar
PubMed
Search for other papers by Alf S. Alving in
Current site
Google Scholar
PubMed
Daniel D. Hankey
Daniel D. Hankey
Search for other papers by Daniel D. Hankey in
Current site
Google Scholar
PubMed
Search for other papers by Daniel D. Hankey in
Current site
Google Scholar
PubMed
G. Robert Coatney
G. Robert Coatney
Search for other papers by G. Robert Coatney in
Current site
Google Scholar
PubMed
Search for other papers by G. Robert Coatney in
Current site
Google Scholar
PubMed
Ralph Jones Jr.
Ralph Jones Jr.
Search for other papers by Ralph Jones Jr. in
Current site
Google Scholar
PubMed
Search for other papers by Ralph Jones Jr. in
Current site
Google Scholar
PubMed
Walter G. Coker
Walter G. Coker
Search for other papers by Walter G. Coker in
Current site
Google Scholar
PubMed
Search for other papers by Walter G. Coker in
Current site
Google Scholar
PubMed
Paul L. Garrison
Paul L. Garrison
Search for other papers by Paul L. Garrison in
Current site
Google Scholar
PubMed
Search for other papers by Paul L. Garrison in
Current site
Google Scholar
PubMed
William N. Donovan
William N. Donovan
Search for other papers by William N. Donovan in
Current site
Google Scholar
PubMed
Search for other papers by William N. Donovan in
Current site
Google Scholar
PubMed
Summary and Conclusion
Fifteen milligrams of primaquine base administered daily for 14 days, in conjunction with standard chloroquine therapy (1.5 gm. base or 2.5 gm. chloroquine diphosphate in 3 days), constitutes the treatment of choice for the radical cure of Plasmodium vivax of Korean origin during late clinical activity. This therapeutic schedule may be safely continued on an ambulatory basis with only minimum medical supervision after acute symptoms have subsided.
Clinically significant toxicity was not observed with either primaquine or pamaquine, although in the dosage employed pamaquine is potentially toxic in a small percentage of Negroes.
Author Notes
Department of Medicine, University of Chicago.
First Lieut., Captain, Captain, Lt. Colonel, respectively, MC, U.S.A.
Laboratory of Tropical Diseases, National Microbiological Institute, National Institutes of Health.
Department of Medicine, University of Pennsylvania.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 347 | 197 | 13 |
| Full Text Views | 3 | 1 | 0 |
| PDF Downloads | 7 | 2 | 0 |